Answers are grounded in this paper and cite their sources.
Injuries to the central nervous system (CNS) can cause severe neurological deficits. Axonal regrowth is a fundamental process for the reconstruction of compensatory neuronal networks after injury; however, it is extremely limited in the adult mammalian CNS. In this study, we conducted a loss-of-function genetic screen in cortical neurons, combined with a web-resource-based phenotypic screen, and identified synaptotagmin 4 (Syt4) as a novel regulator of axon elongation. Silencing Syt4 in primary cultured cortical neurons inhibits neurite elongation, with changes in gene expression involved in signaling pathways related to neuronal development. In a spinal cord injury model, inhibition of Syt4 expression in cortical neurons prevented axonal sprouting of the corticospinal tract, as well as neurological recovery after injury. These results provide a novel therapeutic approach to CNS injury by modulating Syt4 function. Significance Statement Promoting axonal regrowth has been considered a promising therapeutic target for functional recovery after central nervous system injury. In the present study, we used a web-resource-based phenotypic screening followed by loss-of-functional screening for neurite elongation. We identified a novel role of synaptotagmin 4 (Syt4), a well-characterized regulator of synaptic function, in neurite elongation. In addition, Syt4 knockdown in corticospinal tract inhibited axonal regrowth and functional recovery after spinal cord injury. In this way, we provide a new screening method, which allows us to efficiently find new targets regulating CNS therapeutics.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: